Charles Schwab Investment Management Inc Kodiak Sciences Inc. Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 276,550 shares of KOD stock, worth $685,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares

276,550

Previous 263,276 5.04%

Holding current value

$685,844

Previous $1.38 Million 53.11%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$2.29 - $4.48 $30,397 - $59,467	13,274 Added 5.04%	276,550 $649,000
Q1 2024 May 08, 2024	BUY	$3.01 - $7.45 $67,062 - $165,986	22,280 Added 9.24%	263,276 $1.38 Million
Q4 2023 Feb 06, 2024	BUY	$1.4 - $3.24 $4,312 - $9,979	3,080 Added 1.29%	240,996 $732,000
Q3 2023 Nov 08, 2023	SELL	$1.8 - $7.49 $12,924 - $53,778	-7,180 Reduced 2.93%	237,916 $428,000
Q2 2023 Aug 09, 2023	SELL	$4.3 - $9.48 $1,965 - $4,332	-457 Reduced 0.19%	245,096 $1.69 Million
Q1 2023 May 11, 2023	BUY	$4.81 - $8.88 $85,170 - $157,238	17,707 Added 7.77%	245,553 $1.52 Million
Q4 2022 Feb 13, 2023	SELL	$6.52 - $8.05 $57,532 - $71,033	-8,824 Reduced 3.73%	227,846 $1.63 Million
Q3 2022 Nov 14, 2022	SELL	$7.57 - $12.5 $16,676 - $27,537	-2,203 Reduced 0.92%	236,670 $1.83 Million
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.48 $59,905 - $112,679	11,886 Added 5.24%	238,873 $1.83 Million
Q1 2022 May 13, 2022	SELL	$7.09 - $89.45 $73,565 - $928,133	-10,376 Reduced 4.37%	226,987 $1.75 Million
Q4 2021 Feb 11, 2022	BUY	$80.85 - $128.49 $318,225 - $505,736	3,936 Added 1.69%	237,363 $20.1 Million
Q3 2021 Nov 16, 2021	SELL	$81.97 - $106.94 $126,479 - $165,008	-1,543 Reduced 0.66%	233,427 $22.4 Million
Q2 2021 Aug 16, 2021	BUY	$77.2 - $126.54 $373,570 - $612,327	4,839 Added 2.1%	234,970 $21.9 Million
Q1 2021 May 17, 2021	BUY	$110.45 - $164.47 $2.32 Million - $3.46 Million	21,021 Added 10.05%	230,131 $26.1 Million
Q4 2020 Feb 16, 2021	BUY	$60.78 - $154.03 $2.01 Million - $5.1 Million	33,111 Added 18.81%	209,110 $30.7 Million
Q3 2020 Nov 13, 2020	SELL	$45.05 - $59.27 $764,138 - $1.01 Million	-16,962 Reduced 8.79%	175,999 $10.4 Million
Q2 2020 Aug 14, 2020	BUY	$42.74 - $66.25 $1.46 Million - $2.26 Million	34,130 Added 21.49%	192,961 $10.4 Million
Q1 2020 May 15, 2020	SELL	$38.18 - $73.95 $408,106 - $790,451	-10,689 Reduced 6.31%	158,831 $7.58 Million
Q4 2019 Feb 07, 2020	BUY	$13.9 - $76.65 $696,084 - $3.84 Million	50,078 Added 41.93%	169,520 $12.2 Million
Q3 2019 Nov 08, 2019	BUY	$10.24 - $17.57 $415,252 - $712,498	40,552 Added 51.4%	119,442 $1.72 Million
Q2 2019 Aug 09, 2019	BUY	$6.2 - $12.0 $108,438 - $209,880	17,490 Added 28.49%	78,890 $924,000
Q1 2019 May 14, 2019	BUY	$6.43 - $9.44 $52,301 - $76,784	8,134 Added 15.27%	61,400 $401,000
Q4 2018 Feb 14, 2019	BUY	$6.11 - $10.43 $325,455 - $555,564	53,266 New	53,266 $379,000

Others Institutions Holding KOD

# of Institutions

104

Shares Held

39.8M

Call Options Held

7.6K

Put Options Held

3.5K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $129M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Kodiak Sciences Inc. Transaction History